The cJun NH2-terminal kinase (JNK)-signaling pathway is implicated in metabolic syndrome. including dysregulated blood glucose concentration and insulin resistance. Fibroblast growth factor 21 (FGF21) is a target of the hepatic JNK-signaling pathway and may contribute to the regulation of glycemia. To test the role of FGF21. https://balboasurfandsstylers.shop/product-category/aromatherapy/